19 completed, 7 recruiting, 4 unknown, 1 active not recruiting. 12 Not applicable, 10 Phase 2, 7 Phase 1, 1 Phase 3, 1 Phase 4.
Follow Endometrium Cancer: new trials by email Literature Review of Endometrium Cancer trials Research Report on Endometrium Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types IDE034 - Esophageal Squamous Cell Carcinoma, High Grade Serous Ovarian Cancer | Phase 1 | Recruiting | IDEAYA Biosciences | 150 | 2026-02-24 | 2026-06-18 |
| Effect of Motivational Interviewing on Posttraumatic Stress Symptoms and Posttraumatic Growth in Women with Endometrial Cancer Motivational interviewing - Endometrium Cancer, Post Traumatic Stress Symptoms | Not applicable | Not yet recruiting | Akdeniz University | 66 | 2025-02-03 | 2025-01-17 |
| Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment Multi-Professional Guided '5+2' Intermittent Fasting, Low-energy Balanced Diet, Routine Care for Self-weight Management. - Endometrium Cancer | Not applicable | Recruiting | Peking University People's Hospital | 81 | 2025-01-10 | 2026-01-06 |
| Tumor-Infiltrating Lymphocytes in Endometrial Cancer Tumor-infliltrating lymphocyte (TIL) percentage, Grey level co-occurrence matrix (GLCM), Fractal dimension (FD) - Endometrium Cancer, Tumor Infiltration | Completed | Jagiellonian University | 52 | 2024-12-01 | 2025-05-16 | |
| A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer. Endometrium Cancer | Recruiting | Regina Elena Cancer Institute | 40 | 2024-06-20 | 2025-02-24 | |
| The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population Endometrium Cancer, Gynecologic Cancer | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 10000 | 2024-04-01 | 2026-04-30 | |
| Development of a Molecular Diagnostic Tool for Endometrial Cancer. WomEC - Endometrium Cancer | Completed | MiMARK Diagnostics, S.L. | 1950 | 2023-10-18 | 2025-08-28 | |
| A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer VLS-1488 - Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary | Phase 1 / Phase 2 | Recruiting | Volastra Therapeutics, Inc. | 200 | 2023-10-18 | 2025-11-04 |
| Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial Cancer Physical activity - Endometrium Cancer, Physical Activity | Not applicable | Completed | Peking University People's Hospital | 72 | 2023-08-01 | 2025-04-24 |
| Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer Provera - Endometrium Cancer | Phase 4 | Completed | University of British Columbia | 96 | 2023-03-15 | 2026-04-13 |
| PET/CT in the Management of Patients With Early Stage Endometrial Cancer Positron emission tomography and computed tomography, Surgical treatment - Endometrium Cancer | Unknown | Università degli Studi dell'Insubria | 40 | 2022-05-01 | 2021-09-30 | |
| Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment Weight management--diet, Weight management--exercise, Weight management--accompany - Endometrium Cancer | Not applicable | Recruiting | Peking University People's Hospital | 240 | 2022-04-01 | 2025-09-03 |
| A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma Futibatinib, Pembrolizumab - Metastatic Cancer, Endometrium Cancer | Phase 2 | Terminated | M.D. Anderson Cancer Center | 9 | 2021-09-30 | 2026-03-27 |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers SNK01, Trastuzumab, Cetuximab - Advanced Solid Tumor, Metastatic Cancer | Phase 1 / Phase 2 | Withdrawn | NKGen Biotech, Inc. | 2021-03-01 | 2021-05-12 | |
| Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer. Thrombi-Gel, Conventional Pelvic lymphadenectomy - Lymphocele, Lymphocele After Surgical Procedure | Not applicable | Completed | Kocaeli University | 72 | 2019-12-20 | 2020-07-07 |
| Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma Celecoxib 200mg capsule - Endometrium Cancer | Phase 2 | Unknown | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 48 | 2019-11-13 | 2020-01-10 |
| Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study Ataluren + Pembrolizumab - Colorectal Cancer, Endometrium Cancer | Phase 1 / Phase 2 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 47 | 2019-08-01 | 2023-02-01 |
| Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model Endometrium Cancer | Completed | IRCCS San Raffaele | 86 | 2019-07-23 | 2026-09-23 | |
| Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer PARP inhibitor and Anti-PD-L1 - Endometrial Neoplasms, Uterine Neoplasms | Phase 2 | Unknown | Leiden University Medical Center | 55 | 2019-07-08 | 2021-04-01 |
| The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients Logotherapy - Cancer of Ovary, Endometrium Cancer | Not applicable | Completed | Akdeniz University | 68 | 2019-03-25 | 2022-02-18 |
Showing 20 of 35. Sign in to see all of them.
Endometrial Neoplasms (35) · Ovarian Neoplasms (10) · Uterine Cervical Neoplasms (8) · Neoplasms (5) · Squamous Cell Carcinoma of Head and Neck (5) · Carcinoma, Non-Small-Cell Lung (4) · Esophageal Neoplasms (4) · Urinary Bladder Neoplasms (4) · Breast Neoplasms (3) · Colorectal Neoplasms (3) · Neoplasm Metastasis (3) · Prostatic Neoplasms (3) · Triple Negative Breast Neoplasms (3) · Uterine Neoplasms (2) · Anus Neoplasms (1)
Female Urogenital Diseases (35) · Female Urogenital Diseases and Pregnancy Complications (35) · Genital Diseases (35) · Genital Diseases, Female (35) · Urogenital Diseases (35) · Uterine Diseases (35) · Genital Neoplasms, Female (34) · Neoplasms by Site (34) · Urogenital Neoplasms (34) · Uterine Neoplasms (33) · Neoplasms (30) · Adnexal Diseases (10) · Endocrine Gland Neoplasms (10) · Endocrine System Diseases (10) · Gonadal Disorders (10)
tisotumab vedotin (3) · pembrolizumab (2) · Celecoxib (1) · Cetuximab (1) · Control Groups (1) · Cyclooxygenase 2 (1) · Exercise (1) · Indocyanine Green (1) · Infracyanine green (1) · Logotherapy (1) · Medroxyprogesterone Acetate (1) · Motivational Interviewing (1) · NVP-BKM120 (1) · Pemetrexed (1) · Poly(ADP-ribose) Polymerase Inhibitors (1)
Peking University People's Hospital (3) · Seagen Inc. (3) · Akdeniz University (2) · Kocaeli University (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Brazilian National Cancer Institute (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Eli Lilly and Company (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · IDEAYA Biosciences (1) · IRCCS San Raffaele (1) · Institut Paoli-Calmettes (1) · Institut de Cancérologie de Lorraine (1) · Jagiellonian University (1) · Leiden University Medical Center (1)
United States (9) · Turkey (Türkiye) (5) · Italy (4) · Netherlands (4) · Belgium (3) · China (3) · France (3) · United Kingdom (3) · Canada (2) · Denmark (2) · Spain (2) · Brazil (1) · Finland (1) · Hungary (1) · Poland (1)
Johann de Bono, Professor (2) · Adriaan D Bins, MD PhD (1) · Aline Talhouk, PhD (1) · Antonio Gil-Moreno, MD, PhD (1) · Benoit van den Eynde, PhD (1) · Burak Sezgin (1) · David Miller, MD (1) · Francesco Fanfani (1) · Gabriela V Chaves, PhD (1) · Jessica McAlpine, MD (1) · Katherine Tucker, MD (1)
PMID 37496366, PMID 41044356, PMID 24357226, PMID 24866923, PMID 26304900, PMID 27392550, PMID 27480883, PMID 28279480, PMID 28283195, PMID 28937446, PMID 29511906, PMID 30745090, PMID 31796521, PMID 34453569, PMID 36971688, PMID 37642347, PMID 38422947, PMID 40011116, PMID 40983668, PMID 41595203, PMID 41799945
2008 (1), 2017 (1)